busulfan has been researched along with Systemic Inflammatory Response Syndrome in 1 studies
Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever
| Excerpt | Relevance | Reference |
|---|---|---|
| "Secondary hemophagocytic syndrome (HPS) has been described after autologous hematopoietic cell transplant (AutoHCT)." | 1.51 | Secondary hemophagocytic syndrome after autologous hematopoietic cell transplant and immune therapy for neuroblastoma. ( Cervi, D; Epperly, R; Federico, S; Furman, W; Hines, M; Li, Y; Madden, R; Mamcarz, E; Santiago, T; Talleur, A; Triplett, B, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Epperly, R | 1 |
| Furman, W | 1 |
| Hines, M | 1 |
| Santiago, T | 1 |
| Li, Y | 1 |
| Madden, R | 1 |
| Mamcarz, E | 1 |
| Cervi, D | 1 |
| Federico, S | 1 |
| Triplett, B | 1 |
| Talleur, A | 1 |
1 other study available for busulfan and Systemic Inflammatory Response Syndrome
| Article | Year |
|---|---|
Secondary hemophagocytic syndrome after autologous hematopoietic cell transplant and immune therapy for neuroblastoma.
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Chil | 2019 |